Price:
Rs. 35,000.00
Sample Type: Peripheral Blood
Fasting Not Required
Notes:L8171
Frequently Asked Questions (FAQ's):
What does the NextGen LiquiCore 12 Gene Panel test include?
It evaluates 12 key cancer-related genes for actionable mutations that inform diagnosis and treatment.
Who should take this test?
Patients with confirmed cancer, suspected malignancy, or those needing guidance for targeted therapy.
How is the sample collected?
A standard blood sample is collected for NGS-based liquid biopsy analysis.
Can this test guide personalized cancer therapy?
Yes, it identifies actionable mutations to help clinicians select targeted treatments and monitor response.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses next-generation sequencing with stringent quality controls for accurate detection.
Is fasting required for the test?
No fasting is required.
Can this test monitor disease progression?
Yes, serial testing allows tracking of tumor mutations over time.
How long does it take to receive results from Metropolis Healthcare?
Results are generally available within 10–21 days, depending on the complexity of the analysis.